http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-375056-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b04f5b6a02051c94d6eaf190b751ed2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09B1-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09B1-36
filingDate 1931-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1932-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-375056-A
titleOfInvention Process for the manufacture of vat dyestuffs of the anthraquinone series
abstract Cyanuric chloride or its substitution products are condensed with aminoanthraquinones or substitution products thereof containing at least one replaceable hydrogen atom attached to the nitrogen atom in the presence of aromatic hydroxy compounds, but in the absence of acid-binding agents. Suitable aromatic hydroxy compounds are phenol, o- and p-chlorophenol, cresols, and a -naphthol, and while they are preferably employed in sufficient quantity alone, they may be used together with an organic solvent such as nitrobenzene, or o-dichlorobenzene. The components are dissolved in approximately theoretical proportions in the hydroxy body, and condensation preferably effected at temperatures of 80-150 DEG C. In examples, (1) a -aminoanthraquinone (3 mols.) is condensed with cyanuric chloride (1 mol.) in presence of phenol, o-chlorphenol, p-chlorphenol, or a -naphthol: (2) b -aminoanthraquinone (3 mols.) is condensed with cyanuric chloride (1 mol.) in presence of phenol: (3) a -aminoanthraquinone (1 mol.) and b -aminoaminoanthraquinone (2 mols.) are condensed with cyanuric chloride (1 mol.) in presence of p-chlorphenol: (4) 1-amino-4-benzoylaminoanthraquinone (3 mols.) is condensed with cyanuric chloride (1 mol.) in presence of p-chlorphenol: (5) a -aminoanthraquinone (2 mols.) is condensed with phenyldichloro-1.3.5-triazine (1 mol.) in presence of phenol: (6) 4-amino-1.1<1>-dianthraquinonylamine (2 mols.) is condensed with phenyldichlor-1.3.5-triazine (1 mol.) in presence of phenol; both chlorine atoms are replaced in contradistinction to the product obtained when using nitrobenzene as solvent: (7) a -aminoanthraquinone (2 mols.) is condensed with methyldichlor-1.3.5-triazine (1 mol.) in presence of phenol: (8) Bz2-4-dichloro-4-aminoanthraquinone-1.2-benzacridone (2 mols.) is condensed with methyldichloro-1.3.5-triazine (1 mol.) in presence of phenol: (9) a -aminoanthraquinone (2 mols.) is condensed with ethyldichlor-1.3.5-triazine (1 mol.) in presence of p-nitrophenol: (10) 1-amino-4-benzoylaminoanthraquinone (2 mols.) is condensed with cyclohexyldichloro-1.3.5-triazine (1 mol.) (prepared by reacting upon cyanuric chloride with cyclohexyl magnesium bromide) in presence of phenol: (11) 1-amino-5-benzoylaminoanthraquinone (2 mols.) is condensed with benzyldichloro-1.3.5-triazine (1 mol.) (prepared by reacting upon cyanuric chloride with benzyl magnesium bromide) in presence of phenol. Specifications 205,525, 231,688, 234,086, 237,872, 278,728, [all in Class 2 (iii), Dyes &c.], and 350,575 are referred to.
priorityDate 1930-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452037684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449031050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421027906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420129856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406948316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44464442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414879057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15977727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426493161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415735552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415734079
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11085630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414871603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407448183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12776

Total number of triples: 48.